Adenovirus hepatitis presenting as tumoral lesions in an immunocompromised patient

Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 6

Abstract

A 59-year-old man with T-cell prolymphocytic leukemia on alemtuzumab presented with neutropenic fever, intermittent nausea, and multiple ill-defined low attenuation foci in the liver on abdominal computed tomography scan which were suspicious for metastatic disease. Histological examination revealed the diagnosis of adenovirus hepatitis. Patient responded well to cidofovir. Adenovirus hepatitis is a rare but important entity to be considered by the clinicians, radiologists, and pathologists. Timely diagnosis and appropriate management are essential to improve the prognosis of adenovirus hepatitis in immunocompromised patients.

Authors and Affiliations

Juan Putra, Arief A. Suriawinata

Keywords

Related Articles

Prevalence and factors associated with the presence of Abnormal Function Liver Tests in patients with ulcerative colit

Aim. To investigate the prevalence of abnormal function liver tests and risk factors associated with their development in Mexican patients with UC. Methods. A total of 200 patients with confirmed diagnosis of UC were eva...

Adult living donor versus deceased donor liver transplantation: A 10- year prospective single center experience

It has been 4 years since the first, long-term (> 3 years) prospective comparison of adult-to-adult living donor liver transplantation (A2ALLTx) to adult deceased donor liver transplantation (ADDLTx) was repor...

Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites

Introduction. The diagnosis of malignant ascites is a challenging problem in clinical practice, non-invasive techniques should be developed to improve diagnostic accuracy. The diagnostic performances of tumor markers in...

Download PDF file
  • EP ID EP78460
  • DOI -
  • Views 136
  • Downloads 0

How To Cite

Juan Putra, Arief A. Suriawinata (2014). Adenovirus hepatitis presenting as tumoral lesions in an immunocompromised patient. Annals of Hepatology, 13(6), 827-829. https://europub.co.uk./articles/-A-78460